Diabetic nephropathy and inflammation
- PMID: 24936261
- PMCID: PMC4058744
- DOI: 10.4239/wjd.v5.i3.393
Diabetic nephropathy and inflammation
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage renal failure worldwide. Besides, diabetic nephropathy is associated with cardiovascular disease, and increases mortality of diabetic patients. Several factors are involved in the pathophysiology of DN, including metabolic and hemodynamic alterations, oxidative stress, and activation of the renin-angiotensin system. In recent years, new pathways involved in the development and progression of diabetic kidney disease have been elucidated; accumulated data have emphasized the critical role of inflammation in the pathogenesis of diabetic nephropathy. Expression of cell adhesion molecules, growth factors, chemokines and pro-inflammatory cytokines are increased in the renal tissues of diabetic patients, and serum and urinary levels of cytokines and cell adhesion molecules, correlated with albuminuria. In this paper we review the role of inflammation in the development of diabetic nephropathy, discussing some of the major inflammatory cytokines involved in the pathogenesis of diabetic nephropathy, including the role of adipokines, and take part in other mediators of inflammation, as adhesion molecules.
Keywords: Adhesion molecules; Albuminuria; Cytokines; Diabetic Nephropathy; Inflammation.
References
-
- Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–442. - PubMed
-
- Gaballa M, Farag MK. Predictors of Diabetic Nephropathy. Eur J Med. 2013;8:287–296.
-
- Lopez-Parra V, Mallavia B, Egido J, Gomez-Guerrero C. Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options. In: Chan JSD. Diabetic Nephropathy. InTech, Chapters; 2012. pp. 127–146.
-
- Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009;11:e13. - PubMed
-
- Navarro-González JF, Jarque A, Muros M, Mora C, García J. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 2009;20:165–173. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources